IDEAYA Biosciences to Participate in Investor Conferences in September 2022

SOUTH SAN FRANCISCO, Calif., Aug. 30, 2022 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in investor conferences...

Click to view original post